Full Text View
Tabular View
No Study Results Posted
Related Studies
High Dose Nimodipine Treatment Adjunct - 1
This study has been completed.
Study NCT00000332   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: June 23, 2005   History of Changes

September 20, 1999
June 23, 2005
 
 
  • Stimulated and non-stimulated craving
  • Stimulated and non-stimulated withdrawal
  • Anxiety, depression
  • Heart rate
Same as current
Complete list of historical versions of study NCT00000332 on ClinicalTrials.gov Archive Site
 
 
 
High Dose Nimodipine Treatment Adjunct - 1
High Dose Nimodipine Pharmacotherapy Adjunct

The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

 
Phase II
Interventional
Treatment
Cocaine-Related Disorders
Drug: Nimodipine
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
0
 
 

Please contact site for information.

Both
22 Years to 45 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000332
 
NIDA-3-0009-1, Y01-3-0009-1
National Institute on Drug Abuse (NIDA)
Department of Veterans Affairs
Principal Investigator: Steven Deutsch, M.D. Washington DC VA
National Institute on Drug Abuse (NIDA)
December 2002

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP